A comparison of the efficacy of cilazapril versus cilazapril plus hydrochlorothiazide in patients with mild to moderate essential hypertension

European Journal of Clinical Pharmacology

Volumn 44, Issue 4, 1993, Pages 377-379

  Kellaway, G S M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

ACE inhibitor; Cilazapril; cost; efficacy; essential; Hypertension

Indexed keywords

CILAZAPRIL; HYDROCHLOROTHIAZIDE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; CILAZAPRIL; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0027211731     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF00316476     Document Type: Article

References (3)

1. The treatment of moderate to severe hypertension with ACE inhibitors
2. Cilazapril: a new non-thiol-containing-angiotensin-converting enzyme inhibitor
3. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension